These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27558614)

  • 1. Generation of a human induced pluripotent stem cell line via CRISPR-Cas9 mediated integration of a site-specific homozygous mutation in CHMP2B.
    Zhang Y; Schmid B; Nielsen TT; Nielsen JE; Clausen C; Hyttel P; Holst B; Freude KK
    Stem Cell Res; 2016 Jul; 17(1):151-153. PubMed ID: 27558614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a human induced pluripotent stem cell line via CRISPR-Cas9 mediated integration of a site-specific heterozygous mutation in CHMP2B.
    Zhang Y; Schmid B; Nielsen TT; Nielsen JE; Clausen C; Hyttel P; Holst B; Freude KK
    Stem Cell Res; 2016 Jul; 17(1):148-150. PubMed ID: 27558613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of microglial metabolism and inflammatory profile contributes to neurotoxicity in a hiPSC-derived microglia model of frontotemporal dementia 3.
    Haukedal H; Syshøj Lorenzen S; Winther Westi E; Corsi GI; Gadekar VP; McQuade A; Davtyan H; Doncheva NT; Schmid B; Chandrasekaran A; Seemann SE; Cirera S; Blurton-Jones M; Meyer M; Gorodkin J; Aldana BI; Freude K
    Brain Behav Immun; 2023 Oct; 113():353-373. PubMed ID: 37543250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B.
    Zhang Y; Schmid B; Nikolaisen NK; Rasmussen MA; Aldana BI; Agger M; Calloe K; Stummann TC; Larsen HM; Nielsen TT; Huang J; Xu F; Liu X; Bolund L; Meyer M; Bak LK; Waagepetersen HS; Luo Y; Nielsen JE; ; Holst B; Clausen C; Hyttel P; Freude KK
    Stem Cell Reports; 2017 Mar; 8(3):648-658. PubMed ID: 28216144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CHMP2B
    Krasniak CS; Ahmad ST
    Brain Res; 2016 Oct; 1649(Pt B):151-157. PubMed ID: 26972529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Genetics of Frontotemporal Dementia Elucidated by
    Vandal SE; Zheng X; Ahmad ST
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate-glutamine homeostasis is perturbed in neurons and astrocytes derived from patient iPSC models of frontotemporal dementia.
    Aldana BI; Zhang Y; Jensen P; Chandrasekaran A; Christensen SK; Nielsen TT; Nielsen JE; Hyttel P; Larsen MR; Waagepetersen HS; Freude KK
    Mol Brain; 2020 Sep; 13(1):125. PubMed ID: 32928252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
    Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA
    Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.
    Skibinski G; Parkinson NJ; Brown JM; Chakrabarti L; Lloyd SL; Hummerich H; Nielsen JE; Hodges JR; Spillantini MG; Thusgaard T; Brandner S; Brun A; Rossor MN; Gade A; Johannsen P; Sørensen SA; Gydesen S; Fisher EM; Collinge J
    Nat Genet; 2005 Aug; 37(8):806-8. PubMed ID: 16041373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator.
    Shirai R; Cho M; Isogai M; Fukatsu S; Okabe M; Okawa M; Miyamoto Y; Torii T; Yamauchi J
    Neurol Int; 2023 Aug; 15(3):980-993. PubMed ID: 37606396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology.
    Clayton EL; Mizielinska S; Edgar JR; Nielsen TT; Marshall S; Norona FE; Robbins M; Damirji H; Holm IE; Johannsen P; Nielsen JE; Asante EA; Collinge J; ; Isaacs AM
    Acta Neuropathol; 2015 Oct; 130(4):511-23. PubMed ID: 26358247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations.
    Urwin H; Authier A; Nielsen JE; Metcalf D; Powell C; Froud K; Malcolm DS; Holm I; Johannsen P; Brown J; Fisher EM; van der Zee J; Bruyland M; ; Van Broeckhoven C; Collinge J; Brandner S; Futter C; Isaacs AM
    Hum Mol Genet; 2010 Jun; 19(11):2228-38. PubMed ID: 20223751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro.
    van der Zee J; Urwin H; Engelborghs S; Bruyland M; Vandenberghe R; Dermaut B; De Pooter T; Peeters K; Santens P; De Deyn PP; Fisher EM; Collinge J; Isaacs AM; Van Broeckhoven C
    Hum Mol Genet; 2008 Jan; 17(2):313-22. PubMed ID: 17956895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia.
    Rizzu P; van Mil SE; Anar B; Rosso SM; Donker Kaat L; Heutink P; van Swieten JC
    Am J Med Genet B Neuropsychiatr Genet; 2006 Dec; 141B(8):944-6. PubMed ID: 16941655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating Golgi Stress Signaling Ameliorates Cell Morphological Phenotypes Induced by CHMP2B with Frontotemporal Dementia-Associated p.Asp148Tyr.
    Fukatsu S; Okawa M; Okabe M; Cho M; Isogai M; Yokoi T; Shirai R; Oizumi H; Yamamoto M; Ohbuchi K; Miyamoto Y; Yamauchi J
    Curr Issues Mol Biol; 2024 Feb; 46(2):1398-1412. PubMed ID: 38392208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration.
    Lee JA; Beigneux A; Ahmad ST; Young SG; Gao FB
    Curr Biol; 2007 Sep; 17(18):1561-7. PubMed ID: 17683935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CHMP2B in frontotemporal dementia.
    Urwin H; Ghazi-Noori S; Collinge J; Isaacs A
    Biochem Soc Trans; 2009 Feb; 37(Pt 1):208-12. PubMed ID: 19143633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic screen identifies serpin5 as a regulator of the toll pathway and CHMP2B toxicity associated with frontotemporal dementia.
    Ahmad ST; Sweeney ST; Lee JA; Sweeney NT; Gao FB
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12168-73. PubMed ID: 19581577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel splice-site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review.
    Li C; Wen Y; Zhao M; Wang Y; Li P; Wang L; Wang S
    Mol Genet Genomic Med; 2023 Aug; 11(8):e2222. PubMed ID: 37272767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional analysis of the CHMP2B missense mutation associated with neurodegenerative diseases in the endo-lysosomal pathway.
    Han JH; Ryu HH; Jun MH; Jang DJ; Lee JA
    Biochem Biophys Res Commun; 2012 May; 421(3):544-9. PubMed ID: 22521643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.